Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model

Jacqueline Sagen, Hong Wang, George D. Pappas

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Previous work in this laboratory has indicated that the transplantation of adrenal medullary tissue into the subarachnoid space of the rat spinal cord can reduce pain sensitivity to acute noxious stimuli, particularly following stimulation by nicotine. This most likely results from the stimulated release of opioid peptides and catecholamines from the transplanted chromaffin cells. However, chronic pain models may more closely resemble human clinical pain, and the arthritic rat model has been used for screening potential therapeutic strategies. The purpose of the present study was to assess the potential for adrenal medullary tissue implanted into the spinal subarachnoid space to alleviate chronic pain. Adrenal medullary tissue was implanted into adjuvant-induced arthritic rats, and changes in body weight and vocalization responses were monitored over the 10 week course of the disease. Results indicate that the severe weight reduction normally associated with this inflammatory arthritis was attenuated by adrenal medullary, but not control, implants. In addition, vocalizations were reduced in animals implanted with adrenal medullary, but not control tissue following nicotine stimulation. This reduction was blocked by the opiate antagonist, naloxone, and partially attenuated by the alpha-adrenergic antagonist, phentolamine. Together, these results suggest that the transplantation of adrenal medullary tissue into the subarachnoid space of the spinal cord may provide a local source of opioid peptides and catecholamines for the reduction of chronic pain.

Original languageEnglish
Pages (from-to)69-79
Number of pages11
JournalPain
Volume42
Issue number1
StatePublished - Dec 1 1990
Externally publishedYes

Fingerprint

Nociception
Chronic Pain
Spinal Cord
Subarachnoid Space
Opioid Peptides
Nicotine
Arthritis
Catecholamines
Opiate Alkaloids
Transplantation
Adrenergic alpha-Antagonists
Pain
Chromaffin Cells
Body Weight Changes
Experimental Arthritis
Phentolamine
Naloxone
Weight Loss

Keywords

  • Arthritis
  • Catecholamines
  • Chromaffin cells
  • Neural transplants
  • Opioid peptides
  • Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)
  • Neurology
  • Pharmacology
  • Clinical Psychology

Cite this

Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. / Sagen, Jacqueline; Wang, Hong; Pappas, George D.

In: Pain, Vol. 42, No. 1, 01.12.1990, p. 69-79.

Research output: Contribution to journalArticle

Sagen, Jacqueline ; Wang, Hong ; Pappas, George D. / Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model. In: Pain. 1990 ; Vol. 42, No. 1. pp. 69-79.
@article{1188927b7d1a436cbb1c0703287adbe4,
title = "Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model",
abstract = "Previous work in this laboratory has indicated that the transplantation of adrenal medullary tissue into the subarachnoid space of the rat spinal cord can reduce pain sensitivity to acute noxious stimuli, particularly following stimulation by nicotine. This most likely results from the stimulated release of opioid peptides and catecholamines from the transplanted chromaffin cells. However, chronic pain models may more closely resemble human clinical pain, and the arthritic rat model has been used for screening potential therapeutic strategies. The purpose of the present study was to assess the potential for adrenal medullary tissue implanted into the spinal subarachnoid space to alleviate chronic pain. Adrenal medullary tissue was implanted into adjuvant-induced arthritic rats, and changes in body weight and vocalization responses were monitored over the 10 week course of the disease. Results indicate that the severe weight reduction normally associated with this inflammatory arthritis was attenuated by adrenal medullary, but not control, implants. In addition, vocalizations were reduced in animals implanted with adrenal medullary, but not control tissue following nicotine stimulation. This reduction was blocked by the opiate antagonist, naloxone, and partially attenuated by the alpha-adrenergic antagonist, phentolamine. Together, these results suggest that the transplantation of adrenal medullary tissue into the subarachnoid space of the spinal cord may provide a local source of opioid peptides and catecholamines for the reduction of chronic pain.",
keywords = "Arthritis, Catecholamines, Chromaffin cells, Neural transplants, Opioid peptides, Pain",
author = "Jacqueline Sagen and Hong Wang and Pappas, {George D.}",
year = "1990",
month = "12",
day = "1",
language = "English",
volume = "42",
pages = "69--79",
journal = "Pain",
issn = "0304-3959",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model

AU - Sagen, Jacqueline

AU - Wang, Hong

AU - Pappas, George D.

PY - 1990/12/1

Y1 - 1990/12/1

N2 - Previous work in this laboratory has indicated that the transplantation of adrenal medullary tissue into the subarachnoid space of the rat spinal cord can reduce pain sensitivity to acute noxious stimuli, particularly following stimulation by nicotine. This most likely results from the stimulated release of opioid peptides and catecholamines from the transplanted chromaffin cells. However, chronic pain models may more closely resemble human clinical pain, and the arthritic rat model has been used for screening potential therapeutic strategies. The purpose of the present study was to assess the potential for adrenal medullary tissue implanted into the spinal subarachnoid space to alleviate chronic pain. Adrenal medullary tissue was implanted into adjuvant-induced arthritic rats, and changes in body weight and vocalization responses were monitored over the 10 week course of the disease. Results indicate that the severe weight reduction normally associated with this inflammatory arthritis was attenuated by adrenal medullary, but not control, implants. In addition, vocalizations were reduced in animals implanted with adrenal medullary, but not control tissue following nicotine stimulation. This reduction was blocked by the opiate antagonist, naloxone, and partially attenuated by the alpha-adrenergic antagonist, phentolamine. Together, these results suggest that the transplantation of adrenal medullary tissue into the subarachnoid space of the spinal cord may provide a local source of opioid peptides and catecholamines for the reduction of chronic pain.

AB - Previous work in this laboratory has indicated that the transplantation of adrenal medullary tissue into the subarachnoid space of the rat spinal cord can reduce pain sensitivity to acute noxious stimuli, particularly following stimulation by nicotine. This most likely results from the stimulated release of opioid peptides and catecholamines from the transplanted chromaffin cells. However, chronic pain models may more closely resemble human clinical pain, and the arthritic rat model has been used for screening potential therapeutic strategies. The purpose of the present study was to assess the potential for adrenal medullary tissue implanted into the spinal subarachnoid space to alleviate chronic pain. Adrenal medullary tissue was implanted into adjuvant-induced arthritic rats, and changes in body weight and vocalization responses were monitored over the 10 week course of the disease. Results indicate that the severe weight reduction normally associated with this inflammatory arthritis was attenuated by adrenal medullary, but not control, implants. In addition, vocalizations were reduced in animals implanted with adrenal medullary, but not control tissue following nicotine stimulation. This reduction was blocked by the opiate antagonist, naloxone, and partially attenuated by the alpha-adrenergic antagonist, phentolamine. Together, these results suggest that the transplantation of adrenal medullary tissue into the subarachnoid space of the spinal cord may provide a local source of opioid peptides and catecholamines for the reduction of chronic pain.

KW - Arthritis

KW - Catecholamines

KW - Chromaffin cells

KW - Neural transplants

KW - Opioid peptides

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=0025372204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025372204&partnerID=8YFLogxK

M3 - Article

C2 - 2235000

AN - SCOPUS:0025372204

VL - 42

SP - 69

EP - 79

JO - Pain

JF - Pain

SN - 0304-3959

IS - 1

ER -